(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.02%) $0.927
(-0.03%) $10.84
(-0.13%) $0.791
(-0.24%) $92.35
3 days till quarter result
(bmo 2024-04-01)
Expected move: +/- 13.63%
Live Chart Being Loaded With Signals
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union...
Stats | |
---|---|
Today's Volume | 17 740.00 |
Average Volume | 99 945.00 |
Market Cap | 10.01M |
EPS | £0 ( 2023-09-18 ) |
Next earnings date | ( £0 ) 2024-04-01 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | 3.39 |
ATR14 | £0 (0.00%) |
Proteome Sciences PLC Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Proteome Sciences PLC Financials
Annual | 2023 |
Revenue: | £23.50B |
Gross Profit: | £23.50B (100.00 %) |
EPS: | £0.270 |
Q4 | 2023 |
Revenue: | £10.87B |
Gross Profit: | £10.87B (100.00 %) |
EPS: | £0.0744 |
Q2 | 2023 |
Revenue: | £12.63B |
Gross Profit: | £12.62B (99.99 %) |
EPS: | £0.190 |
Q4 | 2022 |
Revenue: | £10.87B |
Gross Profit: | £10.87B (99.99 %) |
EPS: | £0.150 |
Financial Reports:
No articles found.
Proteome Sciences PLC
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators